The Global Conference on Myositis in Lisbon was a great week of science, collaboration, and friendship. Our Portuguese colleagues did a magnificent job of welcoming nearly 700 attendees this year. It is clear that we’re finally entering a new era of therapeutics. #GCOM2026
Delighted to see the VALOR trial, published today in @NEJM: brepocitinib (oral TYK2/JAK1 inhibitor) significantly improved the TIS vs. placebo in treatment-resistant #dermatomyositis (Δ15.3 pts; P<0.001), w/ superiority across all 9 key secondary endpoints — 🧵
Kudos to my colleague and co-first author @JuliePaikMD on this landmark work. Proud to have contributed to the trial design, including a steroid-sparing protocol and integration of patient-reported outcome measures — more on that to come. DOI: 10.1056/NEJMoa2503531 #Myositis
Calcinosis is a painful, disfiguring and debilitating complication of SSc and DM. Our study suggests that 18F-NaF PET/CT may have advantages over expert clinical exam or CT alone for detection/quantification of calcinosis. #myositis #ssc #calcinosis
frontiersin.org/journals/nuc…
I am honored to participate in this Medscape IBM event with my friend and colleague @ElieNaddaf3
Don't miss this fast-paced but deep dive into real-life inclusion body myositis cases, led by @drlisacs + @ElieNaddaf3.
IBM is rare, but the misdiagnoses are common. Get up to speed on what every clinician needs to know! ➡️ ms.spr.ly/6015SdFRL
We had a wonderful time hosting @TheMyositisAssc excursion this past Friday to visit the @Johns Hopkins Myositis Center. So glad we could showcase our amazing group. #jhrheum #myositis @HopkinsMedicine
A big shout out to my amazing mentee and her collaborator. Dr. Julie Paik is brilliant and kind. Richly deserved, and patients will be the beneficiaries. Congratulations @JuliePaikMD !
Thrilled to announce that @PavanBhargavaMD and I have been awarded a UM1 @NIAMSFunding to establish the “Hopkins Autoimmunity Center of Excellence -ACE” as a collab. between @jhrheumatology &neurology! Looking forward to collab w/the ACE network & sharing exciting details ahead!
Today is the day for the EL-PFDD meeting with the @US_FDA. Let us finally come together to design clinical trials in ways that the patients actually experience the disease! Decouple skin & muscle outcomes. #myositis @MyositisSupport @TheMyositisAssc @jhrheumatology
Thrilled to co-author this important viewpoint with @DidemSayginMD and other experts to spark important needed conversation on how we can best conduct #myositis clinical trials to benefit our patients.
📌Check out our viewpoint article to hear our opinions on the current #myositis clinical trial landscape and suggestions to improve the design of and access to trials in myositis @werthlab @DrLisaCS @ingrid_lundberg @MerrileeNeedham @JuliePaikMD @PittRheum 👇
Such a pleasure to host the @JHRheumFellows for cookie decorating and white elephant gift exchange at our home today. A beautiful way to kick off the holiday season.
Christmas cookie decorating + white elephant exchange gift + great company = a cozy kickoff to the holiday season! 🎄🧑🎄
Thanks to @DrLisaCS and @HopkinsMyositis faculty for hosting😍
So lucky to adore my work and my colleagues around the world. What fun!
Amazing myositis session with the wonderful team comprised of @ElieNaddaf3, @DrLisaCS, @drhectorchinoy and @DidemSayginMD! Thank you for all the clinical pearls!
#ACR23 #myositis



























